CMV: when bad viruses turn good
- 4 August 2011
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 118 (5), 1193-1194
- https://doi.org/10.1182/blood-2011-06-354340
Abstract
Cytomegalovirus (CMV) has had a reputation for causing morbidity and mortality after allogeneic stem cell transplantation (SCT). In this issue of Blood, Elmaagacli et al find an unexpected favorable association of a low rate of leukemic relapse in acute myeloid leukemia patients who reactivate CMV in the first few weeks of SCT.1Keywords
This publication has 4 references indexed in Scilit:
- Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patientsBlood, 2011
- Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)–Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2009
- Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failureTransplantation and Cellular Therapy, 2004
- Interstitial pneumonitis following bone marrow transplantation: Pathogenesis and therapeutic considerationsEuropean Journal of Cancer and Clinical Oncology, 1985